Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer

NCT05663723 is registered in ClinicalTrials.gov with Erica Alves Nogueira Fabro as lead sponsor.

NCT NCT05663723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05663723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer
Lead sponsor
Erica Alves Nogueira Fabro
Phase
Not applicable
Overall status
Completed
Start date
March 8, 2023
Completion date
June 4, 2024
Enrollment
186 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral nervous system diseases and breast neoplasms